| Antibiotics | MIC | Susceptibility |
---|---|---|---|
P1 | Penicillin-G | 4 | S |
Ampicillin | ≤2 | S | |
Ampicillin/sulbactam | ≤2 | S | |
Imipenem | ≤1 | S | |
Gentamicin high level | SYN-R | R | |
Streptomycin high-level resistance | SYN-S | S | |
Ciprofloxacin | ≤ 0.5 | S | |
Levofloxacin | 0.5 | S | |
Norfloxacin | 2 | S | |
Erythromycin | ≥ 8 | R | |
Clindamycin | ≥ 8 | R | |
Quinupristin/dalfopristin | 4 | R | |
Linezolid | 2 | S | |
Teicoplanin | ≤ 0.5 | S | |
Vancomycin | 1 | S | |
Tetracycline | ≥ 16 | R | |
Tigecycline | ≤ 0.12 | S | |
Nitrofurantoin | ≤ 16 | S | |
Trimethoprim/sulfamethoxazole | ≤ 10 | R | |
P2 | Ampicillin/sulbactam | ≤ 2 | S |
Ticarcillin/clavulanic acid | ≤ 8 | S | |
Piperacillin | 32 | I | |
Piperacillin/tazobactam | ≤ 4 | S | |
Cefotaxime | 32 | I | |
Ceftazidime | 16 | I | |
Cefepime | 16 | I | |
Aztreonam | 32 | R | |
Imipenem | ≤ 0.25 | S | |
Meropenem | ≤ 0.25 | S | |
Gentamicin | ≤ 1 | S | |
Ciprofloxacin | ≥ 4 | R | |
Minocycline | ≤ 1 | S | |
Tigecycline | ≤ 0.5 | S | |
Trimethoprim/sulfamethoxazole | ≤ 20 | S | |
P3 | Penicillin-G | 1 | I |
Ampicillin | 4 | I | |
Cefotaxime | 0.5 | S | |
Ceftriaxone | 0.5 | S | |
Levofloxacin | 1 | S | |
Moxifloxacin | 0.12 | S | |
Erythromycin | ≤ 0.12 | S | |
Clindamycin | ≤ 0.25 | S | |
Linezolid | ≤ 2 | S | |
Vancomycin | 0.5 | S | |
Tetracycline | 2 | S | |
Tigecycline | ≤ 0.06 | S | |
Chloramphenicol | 2 | S | |
P7 | Ampicillin/sulbactam | ≥ 32 | R |
Ticarcillin/clavulanic acid | 16 | S | |
Piperacillin | ≤ 4 | S | |
Piperacillin/tazobactam | 8 | S | |
Cefotaxime | 16 | R | |
Ceftazidime | 4 | S | |
Cefepime | 2 | S | |
Aztreonam | 2 | S | |
Imipenem | 1 | S | |
Meropenem | ≤ 0.25 | S | |
Amikacin | ≤ 2 | S | |
Gentamicin | 4 | S | |
Ciprofloxacin | ≤ 0.25 | S | |
Minocycline | ≥ 16 | R | |
Tigecycline | ≥ 8 | R | |
Trimethoprim/sulfamethoxazole | 160 | R |